Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diabetes
  Free Subscription

Articles published in
JAMA
    April 2024
  1. MACHIAVELLO ROMAN FJ, Azar MM, Trubin PA
    A Patient With Type 1 Diabetes and Acute Rhinosinusitis.
    JAMA. 2024 Apr 17. doi: 10.1001/jama.2024.0642.
    >> Share

  2. RUBIN R
    All of Us Program Illustrates What Less-Diverse Genomics Studies Might Be Missing.
    JAMA. 2024;331:1167-1168.
    >> Share

  3. HARRIS E
    Less Sleep Tied to Increased Risk of Diabetes Despite Healthy Diet.
    JAMA. 2024 Apr 5. doi: 10.1001/jama.2024.4498.
    >> Share

  4. FANG M, Wang D, Selvin E
    Prevalence of Type 1 Diabetes Among US Children and Adults by Age, Sex, Race, and Ethnicity.
    JAMA. 2024 Apr 4. doi: 10.1001/jama.2024.2103.
    >> Share

  5. POURKARIM F, Entezari-Maleki T
    Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Pregnancy.
    JAMA. 2024 Apr 3. doi: 10.1001/jama.2024.1380.
    >> Share

  6. BOGGESS KA
    Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Pregnancy-Reply.
    JAMA. 2024 Apr 3. doi: 10.1001/jama.2024.1383.
    >> Share

    March 2024
  7. MOZAFFARIAN D
    GLP-1 Agonists for Obesity-A New Recipe for Success?
    JAMA. 2024;331:1007-1008.
    >> Share

  8. THOMAS CC, Chopra K, Davis AM
    Management of Outpatients With Diabetes at High Risk of Hypoglycemia.
    JAMA. 2024 Mar 14. doi: 10.1001/jama.2024.1137.
    >> Share

  9. HARRIS E
    Tirzepatide Lowered Blood Pressure in People With Obesity.
    JAMA. 2024;331:821.
    >> Share

  10. RUDER K
    Diabetic Foot Infections and Amputations Are All Too Common-Here's What Could Move the Needle.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1016.
    >> Share

    February 2024
  11. WADDEN TA, Kushner RF, Chao AM
    Bariatric Surgery Produces Long-Term Benefits in Patients With Type 2 Diabetes: Evidence Supporting Its Expanded Use and Coverage.
    JAMA. 2024;331:643-645.
    >> Share

  12. COURCOULAS AP, Patti ME, Hu B, Arterburn DE, et al
    Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes.
    JAMA. 2024;331:654-664.
    >> Share

  13. MENG J, Tang H, Gao S
    Early Metformin Treatment for Gestational Diabetes.
    JAMA. 2024;331:617-618.
    >> Share

  14. PARK Y, Kim NE, Lee SJ
    Early Metformin Treatment for Gestational Diabetes.
    JAMA. 2024;331:618.
    >> Share

  15. DUNNE F, Newman C, Smyth A
    Early Metformin Treatment for Gestational Diabetes-Reply.
    JAMA. 2024;331:618-619.
    >> Share

  16. CRANE MA, Lam A, Ekanayake E, Alshawkani YY, et al
    Mortality Due to Hyperglycemic Crises in the US, 1999-2022.
    JAMA. 2024;331:440-442.
    >> Share

  17. ALHIARY R, Gabriele S, Kesselheim AS, Tu SS, et al
    Delivery Device Patents on GLP-1 Receptor Agonists.
    JAMA. 2024 Feb 5:e240919. doi: 10.1001/jama.2024.0919.
    >> Share

    January 2024
  18. BELL KJL, Glasziou PP, Doust JA
    Gestational Diabetes and Cardiovascular Health.
    JAMA. 2024;331:167.
    >> Share

  19. VENKATESH KK, Khan SS, Powe CE
    Gestational Diabetes and Cardiovascular Health-Reply.
    JAMA. 2024;331:167-168.
    >> Share

  20. HARRIS E
    "Alarming" Number of Patients Stop Taking Second-Line Diabetes Drugs.
    JAMA. 2024 Jan 3. doi: 10.1001/jama.2023.26110.
    >> Share

  21. HARRIS E
    First Large Study of GLP-1 Receptor Agonists During Pregnancy.
    JAMA. 2024 Jan 3. doi: 10.1001/jama.2023.26112.
    >> Share

  22. ARONNE LJ, Sattar N, Horn DB, Bays HE, et al
    Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.
    JAMA. 2024;331:38-48.
    >> Share

  23. RUDER K
    At ObesityWeek, More Data and Questions About Semaglutide, Tirzepatide, and Retatrutide.
    JAMA. 2024;331:9-11.
    >> Share

    December 2023
  24. JIN J
    What Is Prediabetes?
    JAMA. 2023;330:2404.
    >> Share

  25. HARRIS E
    Lifestyle Changes Lowered Blood Glucose in People With Prediabetes.
    JAMA. 2023;330:2241.
    >> Share

  26. HARRIS E
    Meta-Analysis: Faster Walking Linked With Lower Type 2 Diabetes Risk.
    JAMA. 2023 Dec 13. doi: 10.1001/jama.2023.24686.
    >> Share

  27. FEIG DS
    Metformin for Diabetes in Pregnancy: Are We Closer to Defining Its Role?
    JAMA. 2023;330:2167-2169.
    >> Share

  28. BOGGESS KA, Valint A, Refuerzo JS, Zork N, et al
    Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Early Pregnancy: The MOMPOD Randomized Clinical Trial.
    JAMA. 2023;330:2182-2190.
    >> Share

  29. HARRIS E
    Even Mild Lack of Sleep Might Raise Women's Diabetes Risk.
    JAMA. 2023 Dec 6. doi: 10.1001/jama.2023.24174.
    >> Share

    November 2023
  30. HARRIS E
    Semaglutide Improved Cardiovascular Health in People Without Diabetes.
    JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23508.
    >> Share

  31. ELMALEH-SACHS A, Schwartz JL, Bramante CT, Nicklas JM, et al
    Obesity Management in Adults: A Review.
    JAMA. 2023;330:2000-2015.
    >> Share

  32. VOELKER R
    What Are Diabetic Foot Ulcers?
    JAMA. 2023 Nov 17. doi: 10.1001/jama.2023.17291.
    >> Share

  33. HARRIS E
    Weekly Basal Insulin May Be Equally Effective for Type 1 Diabetes.
    JAMA. 2023 Nov 15. doi: 10.1001/jama.2023.22358.
    >> Share

  34. SODHI M, Rezaeianzadeh R, Kezouh A, Etminan M, et al
    Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss.
    JAMA. 2023;330:1795-1797.
    >> Share

  35. HARRIS E
    Time-Restricted Eating Tested for Weight Loss in Type 2 Diabetes.
    JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.21874.
    >> Share

  36. FENG W, Wang X
    Review of Diabetic Foot Ulcers.
    JAMA. 2023;330:1695.
    >> Share

  37. STRAUSS MB, Wilson K
    Review of Diabetic Foot Ulcers.
    JAMA. 2023;330:1694-1695.
    >> Share

  38. ARMSTRONG DG, Boulton AJM, Bus SA
    Review of Diabetic Foot Ulcers-Reply.
    JAMA. 2023;330:1695-1696.
    >> Share

  39. HARRIS E
    Monoclonal Antibody Slowed Type 1 Diabetes Progression.
    JAMA. 2023 Nov 1. doi: 10.1001/jama.2023.21175.
    >> Share

    October 2023
  40. HARRIS E
    Antivirals Might Preserve Insulin in New-Onset Type 1 Diabetes.
    JAMA. 2023 Oct 25. doi: 10.1001/jama.2023.20633.
    >> Share

  41. HARRIS E
    Large Number of People Diagnosed With Type 1 Diabetes After Age 30.
    JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19207.
    >> Share

  42. ROSENSTOCK J, Frias JP, Rodbard HW, Tofe S, et al
    Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial.
    JAMA. 2023 Oct 3:e2320294. doi: 10.1001/jama.2023.20294.
    >> Share

  43. DUNNE F, Newman C, Alvarez-Iglesias A, Ferguson J, et al
    Early Metformin in Gestational Diabetes: A Randomized Clinical Trial.
    JAMA. 2023 Oct 3:e2319869. doi: 10.1001/jama.2023.19869.
    >> Share

    September 2023
  44. HARRIS E
    Semaglutide Associated With Less Insulin Need in Early Type 1 Diabetes.
    JAMA. 2023 Sep 20. doi: 10.1001/jama.2023.17818.
    >> Share

  45. HARRIS E
    Staying Up Late Tied to Unhealthful Lifestyle, Increased Diabetes Risk.
    JAMA. 2023 Sep 20. doi: 10.1001/jama.2023.17826.
    >> Share

  46. LUGAR M, Eugster A, Achenbach P, von dem Berge T, et al
    SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood.
    JAMA. 2023 Sep 8. doi: 10.1001/jama.2023.16348.
    >> Share

    August 2023
  47. HSU NC, Fu YC, Hsu CH
    Coordinated Care for Optimization of Cardiovascular Preventive Therapies in Patients With Diabetes.
    JAMA. 2023;330:771.
    >> Share

  48. PAGIDIPATI NJ, Granger CB, Nelson A
    Coordinated Care for Optimization of Cardiovascular Preventive Therapies in Patients With Diabetes-Reply.
    JAMA. 2023;330:771-772.
    >> Share

  49. HELGASON H, Eiriksdottir T, Ulfarsson MO, Choudhary A, et al
    Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular Events.
    JAMA. 2023;330:725-735.
    >> Share

  50. ALHIARY R, Kesselheim AS, Gabriele S, Beall RF, et al
    Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists.
    JAMA. 2023;330:650-657.
    >> Share

  51. VENKATESH KK, Khan SS, Powe CE
    Gestational Diabetes and Long-Term Cardiometabolic Health.
    JAMA. 2023 Aug 10. doi: 10.1001/jama.2023.14997.
    >> Share

  52. ENTEZARI-MALEKI T
    Review of Prediabetes.
    JAMA. 2023;330:563-564.
    >> Share

  53. DAVIDSON MB
    Review of Prediabetes.
    JAMA. 2023;330:564.
    >> Share

  54. DAGOGO-JACK S
    Review of Prediabetes-Reply.
    JAMA. 2023;330:564-565.
    >> Share

    July 2023
  55. HSU NC, Tsai HB, Hsu CH
    Verapamil and Pancreatic Beta Cell Function in Pediatric Type 1 Diabetes.
    JAMA. 2023;330:380.
    >> Share

  56. FORLENZA GP, Schamberger MS, Buckingham BA
    Verapamil and Pancreatic Beta Cell Function in Pediatric Type 1 Diabetes-Reply.
    JAMA. 2023;330:380.
    >> Share

  57. ABBASI J
    New Weight Loss Drugs Make Headlines at Diabetes Meeting.
    JAMA. 2023 Jul 12. doi: 10.1001/jama.2023.12718.
    >> Share

  58. HARRIS E
    FDA Greenlights First Cell Therapy for Adults With Type 1 Diabetes.
    JAMA. 2023 Jul 12. doi: 10.1001/jama.2023.12542.
    >> Share

  59. HARRIS E
    Oral Empagliflozin Receives FDA Approval for Children With Diabetes.
    JAMA. 2023 Jul 5. doi: 10.1001/jama.2023.12057.
    >> Share

  60. ARMSTRONG DG, Tan TW, Boulton AJM, Bus SA, et al
    Diabetic Foot Ulcers: A Review.
    JAMA. 2023;330:62-75.
    >> Share

    June 2023
  61. LINGVAY I, Asong M, Desouza C, Gourdy P, et al
    Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes: The ONWARDS 3 Randomized Clinical Trial.
    JAMA. 2023 Jun 24. doi: 10.1001/jama.2023.11313.
    >> Share

  62. HARRIS E
    Patients With Diabetes Turn to Crowdfunding for Expenses.
    JAMA. 2023 Jun 21. doi: 10.1001/jama.2023.10736.
    >> Share

  63. HARRIS E
    Oral Semaglutide Led to Similar Weight Loss as Injection, Company Says.
    JAMA. 2023;329:2011.
    >> Share

  64. SURAN M
    Sugar Substitutes Don't Help Weight Control and May Increase Risk of Heart Disease and Diabetes, WHO Warns.
    JAMA. 2023 Jun 14. doi: 10.1001/jama.2023.10967.
    >> Share


  65. The Routine Treatment of Diabetes With Insulin.
    JAMA. 2023;329:1888.
    >> Share

    May 2023
  66. HARRIS E
    FDA Greenlights Automated Insulin Dosing System for Type 1 Diabetes.
    JAMA. 2023 May 31. doi: 10.1001/jama.2023.9602.
    >> Share

  67. KANCLERZ P, Tuuminen R
    Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy.
    JAMA. 2023;329:1795-1796.
    >> Share

  68. SUN JK, Glassman AR, Maturi RK
    Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy-Reply.
    JAMA. 2023;329:1796.
    >> Share

  69. WEISS A, Donnachie E, Beyerlein A, Ziegler AG, et al
    Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19.
    JAMA. 2023 May 22:e238674. doi: 10.1001/jama.2023.8674.
    >> Share

    April 2023
  70. HERMAN WH
    Prediabetes Diagnosis and Management.
    JAMA. 2023;329:1157-1159.
    >> Share

  71. ECHOUFFO-TCHEUGUI JB, Perreault L, Ji L, Dagogo-Jack S, et al
    Diagnosis and Management of Prediabetes: A Review.
    JAMA. 2023;329:1206-1216.
    >> Share

    March 2023
  72. HARRIS E
    Artificial Pancreas Improved Outcomes in Children With Type 1 Diabetes.
    JAMA. 2023 Mar 29. doi: 10.1001/jama.2023.5259.
    >> Share

  73. SURAN M
    All 3 Major Insulin Manufacturers Are Cutting Their Prices-Here's What the News Means for Patients With Diabetes.
    JAMA. 2023 Mar 29. doi: 10.1001/jama.2022.11688.
    >> Share

  74. FANG M, Selvin E
    Cost-Related Insulin Rationing in US Adults Younger Than 65 Years With Diabetes.
    JAMA. 2023 Mar 29:e235747. doi: 10.1001/jama.2023.5747.
    >> Share

  75. DEWANE M, Kroshinsky D
    A Patient With Diabetes and Spontaneous Blistering of the Right Lower Extremity.
    JAMA. 2023 Mar 24. doi: 10.1001/jama.2023.3101.
    >> Share

  76. REDFIELD MM, Borlaug BA
    Heart Failure With Preserved Ejection Fraction: A Review.
    JAMA. 2023;329:827-838.
    >> Share

  77. VALENT AM, Caughey AB
    Comprehensive Management of Type 2 Diabetes During Pregnancy.
    JAMA. 2023 Mar 10. doi: 10.1001/jama.2023.0929.
    >> Share

  78. PAGIDIPATI NJ, Nelson AJ, Kaltenbach LA, Leyva M, et al
    Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial.
    JAMA. 2023 Mar 6:e232854. doi: 10.1001/jama.2023.2854.
    >> Share

  79. AGGARWAL R, Yeh RW, Joynt Maddox KE, Wadhera RK, et al
    Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020.
    JAMA. 2023 Mar 5:e232307. doi: 10.1001/jama.2023.2307.
    >> Share

    February 2023
  80. FORLENZA GP, McVean J, Beck RW, Bauza C, et al
    Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial.
    JAMA. 2023 Feb 24. doi: 10.1001/jama.2023.2064.
    >> Share

  81. COUPER J
    Preserving Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes.
    JAMA. 2023 Feb 24. doi: 10.1001/jama.2023.2140.
    >> Share

  82. MCVEAN J, Forlenza GP, Beck RW, Bauza C, et al
    Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial.
    JAMA. 2023 Feb 24. doi: 10.1001/jama.2023.2063.
    >> Share

  83. HARRIS E
    MicroRNAs Expressed in Pancreatic Islets Linked With Type 2 Diabetes.
    JAMA. 2023 Feb 22. doi: 10.1001/jama.2023.2097.
    >> Share

  84. HARRIS E
    Meta-analysis: Vitamin D Therapy Reduced Type 2 Diabetes.
    JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1550.
    >> Share

  85. CHANG R
    SARS-CoV-2 Infection and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents.
    JAMA. 2023;329:512.
    >> Share

  86. REWERS M, Ziegler AG
    SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents-Reply.
    JAMA. 2023;329:512-513.
    >> Share

  87. SEDERHOLM LAWESSON S, Swahn E, Pihlsgard M, Andersson T, et al
    Association Between History of Adverse Pregnancy Outcomes and Coronary Artery Disease Assessed by Coronary Computed Tomography Angiography.
    JAMA. 2023;329:393-404.
    >> Share

  88. MATURI RK, Glassman AR, Josic K, Baker CW, et al
    Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
    JAMA. 2023;329:376-385.
    >> Share

    January 2023
  89. HARRIS E
    Stroke Risk From Diabetes, High Blood Pressure May Decrease With Age.
    JAMA. 2023 Jan 25. doi: 10.1001/jama.2023.0390.
    >> Share

  90. SLOMSKI A
    Low-Carbohydrate, High-Fat Diet Improved Type 2 Diabetes Without Restricting Calories.
    JAMA. 2023;329:278.
    >> Share

  91. LARKIN H
    More Adolescents and Young Adults Developing Type 2 Diabetes Around the World.
    JAMA. 2023;329:200.
    >> Share

  92. LARKIN H
    New Drug Delays Type 1 Diabetes Onset.
    JAMA. 2023;329:14.
    >> Share

  93. REDMOND B
    The Scent of Hope.
    JAMA. 2023;329:21-22.
    >> Share

    December 2022
  94. LARKIN H
    Wide Variation in Reported Type 1 Diabetes Incidence in Children Around the World.
    JAMA. 2022;328:2295.
    >> Share

    November 2022
  95. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;328:1945-1950.
    >> Share

  96. LARKIN HD
    Bionic Pancreas Outperforms Standard Care for Type 1 Diabetes in Trial.
    JAMA. 2022;328:1798-1799.
    >> Share

  97. LARKIN HD
    Cybersecurity Risk for Medtronic Insulin Pump.
    JAMA. 2022;328:1679.
    >> Share

    October 2022
  98. SLOMSKI A
    Trial Compares Glucose-Lowering Drugs for Type 2 Diabetes.
    JAMA. 2022;328:1581.
    >> Share

  99. SLOMSKI A
    Large Treatment Effects With Automated Insulin Delivery System.
    JAMA. 2022;328:1581-1582.
    >> Share

  100. KE C, Lipscombe LL, Weisman A, Zhou L, et al
    Trends in the Association Between Diabetes and Cardiovascular Events, 1994-2019.
    JAMA. 2022 Oct 14. pii: 2797494. doi: 10.1001/jama.2022.14914.
    >> Share

  101. LARKIN HD
    Open-source Closed-Loop System Is Effective for Type 1 Diabetes.
    JAMA. 2022;328:1387-1388.
    >> Share

    September 2022
  102. ISGANAITIS E, Laffel L
    Recommendations for Screening Children and Adolescents for Prediabetes and Type 2 Diabetes.
    JAMA. 2022;328:933-934.
    >> Share

  103. JIN J
    Screening for Type 2 Diabetes in Children and Adolescents.
    JAMA. 2022;328:993.
    >> Share

  104. JONAS DE, Vander Schaaf EB, Riley S, Allison BA, et al
    Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2022;328:968-979.
    >> Share

  105. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;328:963-967.
    >> Share

  106. ESSIEN UR, Washington DL, Fine MJ
    Beyond Detecting and Understanding Disparities in Novel Diabetes Treatment: Need for a Major Shift in Pharmacoequity Research.
    JAMA. 2022;328:836-838.
    >> Share

  107. SLOMSKI A
    Benefit of Dapagliflozin When Used With Cardiovascular Medications in Patients With Type 2 Diabetes.
    JAMA. 2022;328:817.
    >> Share

  108. LAMPREA-MONTEALEGRE JA, Madden E, Tummalapalli SL, Peralta C, et al
    Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System.
    JAMA. 2022;328:861-871.
    >> Share

    August 2022
  109. REWERS M, Bonifacio E, Ewald D, Geno Rasmussen C, et al
    SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents From Colorado, USA, and Bavaria, Germany.
    JAMA. 2022 Aug 5. pii: 2795226. doi: 10.1001/jama.2022.14092.
    >> Share

    July 2022
  110. HEYBORNE K, Barbour L
    Risk of Adverse Pregnancy Outcomes Among US Individuals With Gestational Diabetes by Race and Ethnicity.
    JAMA. 2022;328:396-397.
    >> Share

  111. GEMMILL A, Leonard SA
    Risk of Adverse Pregnancy Outcomes Among US Individuals With Gestational Diabetes by Race and Ethnicity.
    JAMA. 2022;328:397.
    >> Share

  112. VENKATESH KK, Lynch CD, Grobman WA
    Risk of Adverse Pregnancy Outcomes Among US Individuals With Gestational Diabetes by Race and Ethnicity-Reply.
    JAMA. 2022;328:397-398.
    >> Share

  113. SLOMSKI A
    Tirzepatide Trial Demonstrates Substantial Weight Loss.
    JAMA. 2022;328:322.
    >> Share

  114. JIANG C, Cifu AS, Sam S
    Obesity and Weight Management for Prevention and Treatment of Type 2 Diabetes.
    JAMA. 2022 Jul 11. pii: 2794311. doi: 10.1001/jama.2022.10338.
    >> Share

    May 2022
  115. SLOMSKI A
    Dapagliflozin Safe and Effective for Heart Failure With Frailty.
    JAMA. 2022;327:1950.
    >> Share

  116. GOODWIN PJ, Chen BE, Gelmon KA, Whelan TJ, et al
    Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
    JAMA. 2022;327:1963-1973.
    >> Share

  117. FANG M, Wang D, Echouffo-Tcheugui JB, Selvin E, et al
    Prediabetes and Diabetes Screening Eligibility and Detection in US Adults After Changes to US Preventive Services Task Force and American Diabetes Association Recommendations.
    JAMA. 2022;327:1924-1925.
    >> Share

  118. TU WJ, Xue Y, Nie D
    The Prevalence and Treatment of Diabetes in China From 2013 to 2018.
    JAMA. 2022;327:1706.
    >> Share

  119. WANG L, Wu J, Wang Y
    The Prevalence and Treatment of Diabetes in China From 2013 to 2018-Reply.
    JAMA. 2022;327:1706-1707.
    >> Share

    April 2022
  120. VENKATESH KK, Lynch CD, Powe CE, Costantine MM, et al
    Risk of Adverse Pregnancy Outcomes Among Pregnant Individuals With Gestational Diabetes by Race and Ethnicity in the United States, 2014-2020.
    JAMA. 2022;327:1356-1367.
    >> Share

  121. LARKIN HD
    FDA Expands Empagliflozin Heart Failure Indication.
    JAMA. 2022;327:1219.
    >> Share

    March 2022
  122. SLOMSKI A
    Intensive Glycemic Treatment Reduces Diabetic Foot Ulcers.
    JAMA. 2022;327:1118.
    >> Share

    February 2022
  123. KUEHN BM
    COVID-19 Linked With Increased Incidence of Youth Diabetes.
    JAMA. 2022;327:711.
    >> Share

  124. KAMEL KS, Schreiber M, Harel Z
    Hypernatremia.
    JAMA. 2022;327:774-775.
    >> Share

  125. CHIPKIN SR
    Tirzepatide for Patients With Type 2 Diabetes.
    JAMA. 2022;327:529-530.
    >> Share

  126. DAHL D, Onishi Y, Norwood P, Huh R, et al
    Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
    JAMA. 2022;327:534-545.
    >> Share

  127. SLOMSKI A
    New Data on Retinopathy in Youth-Onset Type 2 Diabetes.
    JAMA. 2022;327:416.
    >> Share

    January 2022
  128. RAY JG, Abdulaziz KE, Berger H
    Aspirin Use for Preeclampsia Prevention Among Women With Prepregnancy Diabetes, Obesity, and Hypertension.
    JAMA. 2022;327:388-390.
    >> Share

  129. RUBINO DM, Greenway FL, Khalid U, O'Neil PM, et al
    Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.
    JAMA. 2022;327:138-150.
    >> Share

  130. KUEHN BM
    Younger Adults With Diabetes Miss Care, Disregard COVID-19 Precautions.
    JAMA. 2022;327:116.
    >> Share

    December 2021
  131. SLOMSKI A
    Tirzepatide Tested for Type 2 Diabetes With High Cardiovascular Risk.
    JAMA. 2021;326:2464.
    >> Share

  132. WANG L, Peng W, Zhao Z, Zhang M, et al
    Prevalence and Treatment of Diabetes in China, 2013-2018.
    JAMA. 2021;326:2498-2506.
    >> Share

  133. SLOMSKI A
    Statin Use Is Associated With Diabetes Progression.
    JAMA. 2021;326:2120.
    >> Share

    October 2021
  134. VOELKER R
    Supplement Marketers Are Warned About Diabetes Claims.
    JAMA. 2021;326:1472.
    >> Share

  135. CHU PJ
    Continuous Glucose Monitoring Use and Access Disparities.
    JAMA. 2021;326:1438.
    >> Share

  136. KARTER AJ, Gilliam LK, Dlott R
    Continuous Glucose Monitoring Use and Access Disparities-Reply.
    JAMA. 2021;326:1438.
    >> Share

  137. SLOMSKI A
    Cycling May Lower Mortality Risk in People Who Have Diabetes.
    JAMA. 2021;326:1246.
    >> Share

  138. COWART K, Carris NW
    Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin.
    JAMA. 2021;326:1329-1330.
    >> Share

  139. HERNANDEZ-NUNEZ W, Villareal-Perez JZ, Rodriguez-Gutierrez R
    Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin.
    JAMA. 2021;326:1330.
    >> Share

  140. MARTENS TW, Beck RW, Bergenstal RM
    Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin-Reply.
    JAMA. 2021;326:1330-1331.
    >> Share

    September 2021
  141. SLOMSKI A
    Closed-Loop Insulin Delivery for Outpatients With Type 2 Diabetes.
    JAMA. 2021;326:1139.
    >> Share

  142. LITTLE RJ, Lewis RJ
    Estimands, Estimators, and Estimates.
    JAMA. 2021;326:967-968.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016